This statement addresses the use of somatostatin-receptor ligands (SRLs) as preoperative therapy for individuals with acromegaly to improve outcomes. DOI: 10.4158/EP14575.DSCR
Read Consensus Statement
2015 Consensus Statement for Pre-Operative Therapy in Management of Patients with Acromegaly